Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label follow-up of levetiracetam monotherapy in epilepsy (N01175 extension)
2006-000173-29Phase 3Completed
- Sponsor
- UCB
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in epilepsy, sponsored by UCB. Primary endpoints: Adverse events and serious adverse events and Body weight changes. Started Apr 2006; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2006-000173-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000173-29.